NU SKIN ENTERPRISES, INC. SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense
NU SKIN ENTERPRISES, INC. (NUS) reported SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense of $1.38 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Valuation and Qualifying Accounts
us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense · last filed 2026-08-10
- NU SKIN ENTERPRISES, INC. sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for the quarter ending 2026-06-30 was $1.38M, a 49.17% decline year-over-year.
- NU SKIN ENTERPRISES, INC. sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for the quarter ending 2026-03-31 was $4.75M, a 53.97% increase year-over-year.
- NU SKIN ENTERPRISES, INC. sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for the quarter ending 2025-12-31 was -$2.04M, a 105.25% decline year-over-year.
- NU SKIN ENTERPRISES, INC. sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for the quarter ending 2025-09-30 was $43.00K, a 97.29% decline year-over-year.
- NU SKIN ENTERPRISES, INC. sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2025 was $3.81M, a 92.10% decline from fiscal 2024.
- NU SKIN ENTERPRISES, INC. sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2024 was $48.21M, a 45.28% decline from fiscal 2023.
- NU SKIN ENTERPRISES, INC. sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2023 was $88.11M, a 103.55% increase from fiscal 2022.
- NU SKIN ENTERPRISES, INC. sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2022 was $43.29M.
| Period end | SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense 3 month | SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense 3 month as first filed | SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense 6 month | SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense 9 month | SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $1.38M 10-Q · filed 2026-08-10 | $6.13M 10-Q · filed 2026-08-10 | $4.09M derived: sum of 3 quarters · filed 2026-08-10 | $4.14M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2026-03-31 | $4.75M 10-Q · filed 2026-05-08 | $2.71M derived: sum of 2 quarters · filed 2026-05-08 | $2.76M derived: sum of 3 quarters · filed 2026-05-08 | $5.47M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-12-31 | -$2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$1.99M derived: sum of 2 quarters · filed 2026-02-13 | $722.00K derived: sum of 3 quarters · filed 2026-08-10 | $3.81M 10-K · filed 2026-02-13 | |
| 2025-09-30 | $43.00K 10-Q · filed 2025-11-07 | $2.76M derived: sum of 2 quarters · filed 2026-08-10 | $5.84M 10-Q · filed 2025-11-07 | $44.64M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-06-30 | $2.71M 10-Q · filed 2026-08-10 | $5.80M 10-Q · filed 2026-08-10 | $44.60M derived: sum of 3 quarters · filed 2026-08-10 | $46.18M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-03-31 | $3.08M 10-Q · filed 2026-05-08 | $41.88M derived: sum of 2 quarters · filed 2026-05-08 | $43.47M derived: sum of 3 quarters · filed 2026-05-08 | $44.99M derived: sum of 4 quarters · filed 2026-05-08 | |
| 2024-12-31 | $38.80M 10-K · filed 2026-02-13 | $40.38M derived: sum of 2 quarters · filed 2026-02-13 | $41.90M derived: sum of 3 quarters · filed 2026-02-13 | $48.21M 10-K · filed 2026-02-13 | |
| 2024-09-30 | $1.58M 10-Q · filed 2025-11-07 | $3.10M derived: sum of 2 quarters · filed 2025-11-07 | $5.10M 10-Q · filed 2025-11-07 | $9.57M derived: sum of 4 quarters · filed 2026-02-13 | |
| 2024-06-30 | $1.52M 10-Q · filed 2025-08-08 | $3.52M 10-Q · filed 2025-08-08 | $7.99M derived: sum of 3 quarters · filed 2026-02-13 | $73.69M derived: sum of 4 quarters · filed 2026-02-13 | |
| 2024-03-31 | $2.00M 10-Q · filed 2025-05-09 | $6.47M derived: sum of 2 quarters · filed 2026-02-13 | $72.17M derived: sum of 3 quarters · filed 2026-02-13 | $83.98M derived: sum of 4 quarters · filed 2026-02-13 | |
| 2023-12-31 | $4.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $70.17M derived: sum of 2 quarters · filed 2026-02-13 | $81.98M derived: sum of 3 quarters · filed 2026-02-13 | $88.11M 10-K · filed 2026-02-13 | |
| 2023-09-30 | $65.70M 10-K · filed 2026-02-13 | $68.56M 10-Q · filed 2023-11-02 | $77.51M derived: sum of 2 quarters · filed 2026-02-13 | $83.64M 10-Q · filed 2024-11-08 | $86.20M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-06-30 | $11.81M 10-Q · filed 2024-08-09 | $15.08M 10-Q · filed 2024-08-09 | $20.50M derived: sum of 3 quarters · filed 2025-02-14 | $47.40M derived: sum of 4 quarters · filed 2025-02-14 | |
| 2023-03-31 | $3.27M 10-Q · filed 2024-05-09 | $8.69M derived: sum of 2 quarters · filed 2025-02-14 | $35.59M derived: sum of 3 quarters · filed 2025-02-14 | ||
| 2022-12-31 | $5.42M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $32.32M derived: sum of 2 quarters · filed 2025-02-14 | $43.29M 10-K · filed 2025-02-14 | ||
| 2022-09-30 | $26.90M 10-K · filed 2025-02-14 | $26.98M 10-Q · filed 2023-11-02 | $37.86M 10-Q · filed 2023-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B | |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |